Kiran Mazumdar Shaw-backed Immuneel rolls out CAR-T cancer therapy in India today, will focus on affordability
The startup, co-founded by Kiran Mazumdar-Shaw, was the first company in India to conduct CAR T-cell therapy trials in 2022. The therapy, called Qartemi, is used to treat adult B-cell non-hodgkin lymphoma, and has been licensed from the Hospital ClĂnic de Barcelona (HCB) of Spain. CAR T-cell therapy involves genetically engineering a patient’s T cells,…